<DOC>
	<DOCNO>NCT00028301</DOCNO>
	<brief_summary>This study compare 2 treatment way affect cholesterol level amount HIV blood .</brief_summary>
	<brief_title>Atazanavir Versus Lopinavir/Ritonavir ( LPV/RTV ) Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen ( )</brief_title>
	<detailed_description>The study design determine metabolic change , antiviral activity , safety , tolerability atazanavir compare LPV/RTV , combination 2 nucleoside , initial 24 week , final analysis 48 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are receive PIcontaining highly active antiretroviral therapy ( HAART ) least 12 week . Have viral load 1,000 copies/ml within 4 week screen within 4 week prior randomization . Have 2 CD4 cell count 50 cells/mm3 least 96 hour apart within 4 week randomization . Are least 16 year old . Have document virologic response least 1 HAART regimen . Have phenotypic sensitivity least 2 follow : ddl , d4T , ZDV , 3TC , ABC . Have phenotypic sensitivity atazanavir LPV/RTV . Use effective barrier method birth control . Will available 48 week . Exclusion Criteria Patients eligible study : Have take 2 PIs virologic failure . Have take atazanavir LPV/RTV . Have HIVrelated infection ( within 30 day ) medical condition require treatment time enrollment . Have acute hepatitis 30 day prior study entry . Have receive certain drug within 3 month study start expect need time enrollment . Abuse alcohol drug way would interfere study . Have bad diarrhea within 30 day prior study entry . Are pregnant breastfeeding . Have history hemophilia . Use lipidlowering drug ( within previous 30 day ) . Have cardiomyopathy symptom heart disease . Can take medicine mouth . Have condition would interfere study . Have pancreatitis , choose ddI part NRTI pair . Have bilateral peripheral neuropathy time screening , choose ddI d4T part NRTI pair .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Lipids</keyword>
	<keyword>ABT 378</keyword>
	<keyword>Antiretroviral Therapy , Highly Active</keyword>
	<keyword>Lipoproteins , LDL Cholesterol</keyword>
</DOC>